【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 6
List of Figures 8
Introduction 9
Global Markets Direct Report Coverage 9
Graft Versus Host Disease (GVHD) Overview 10
Therapeutics Development 11
Pipeline Products for Graft Versus Host Disease (GVHD) – Overview 11
Pipeline Products for Graft Versus Host Disease (GVHD) – Comparative Analysis 12
Graft Versus Host Disease (GVHD) – Therapeutics under Development by Companies 13
Graft Versus Host Disease (GVHD) – Therapeutics under Investigation by Universities/Institutes 18
Graft Versus Host Disease (GVHD) – Pipeline Products Glance 19
Late Stage Products 19
Clinical Stage Products 20
Early Stage Products 21
Unknown Stage Products 22
Graft Versus Host Disease (GVHD) – Products under Development by Companies 23
Graft Versus Host Disease (GVHD) – Products under Investigation by Universities/Institutes 27
Graft Versus Host Disease (GVHD) – Companies Involved in Therapeutics Development 28
AbGenomics International, Inc. 28
Adienne Pharma & Biotech 29
Alder Biopharmaceuticals Inc. 30
Alexion Pharmaceuticals, Inc. 31
Apceth GmbH & Co. KG 32
Athersys, Inc. 33
Bellicum Pharmaceuticals, Inc. 34
Biogen Idec Inc. 35
Dr. Falk Pharma GmbH 36
Enlivex Therapeutics Ltd 37
Escape Therapeutics, Inc. 38
F. Hoffmann-La Roche Ltd. 39
Generon (Shanghai) Corporation Ltd. 40
Idera Pharmaceuticals, Inc. 41
ImmuNext, Inc. 42
Immunomedics, Inc. 43
Jazz Pharmaceuticals plc 44
Kadmon Corporation, LLC 45
Kamada Ltd. 46
Kymab Limited 47
Lycera Corp. 48
Mesoblast Limited 49
Millennium Pharmaceuticals, Inc. 50
MSM Protein Technologies, Inc. 51
Neopharm Ltd. 52
NeoStem, Inc. 53
Novartis AG 54
Omni Bio Pharmaceutical Inc. 55
Pharmacyclics, Inc. 56
Pharmicell Co., Ltd. 57
Pluristem Therapeutics Inc. 58
R-Tech Ueno, Ltd. 59
REGiMMUNE Corporation 60
Rigel Pharmaceuticals, Inc. 61
Sarepta Therapeutics, Inc. 62
Seattle Genetics, Inc. 63
Sigmoid Pharma Limited 64
Soligenix, Inc. 65
Spherium Biomed S.L. 66
Targazyme, Inc. 67
Therapix Biosciences Ltd 68
Tobira Therapeutics, Inc. 69
Xenikos B.V. 70
Graft Versus Host Disease (GVHD) – Therapeutics Assessment 71
Assessment by Monotherapy Products 71
Assessment by Combination Products 72
Assessment by Target 73
Assessment by Mechanism of Action 76
Assessment by Route of Administration 79
Assessment by Molecule Type 81
Drug Profiles 83
AbGn-168H – Drug Profile 83
aldesleukin – Drug Profile 85
Alecmestencel-L – Drug Profile 87
Alpha-1 Antitrypsin – Drug Profile 88
alpha-1 proteinase inhibitor (human) – Drug Profile 89
ALXN-1007 – Drug Profile 91
anti-thymocyte globulin (rabbit) – Drug Profile 92
Antibodies to Antagonize CD40L for Autoimmune Diseases and GVHD – Drug Profile 94
Antisense Oligonucleotide to Inhibit TLRs for Systemic Lupus Erythematosus and Graft Versus Host Disease – Drug Profile 95
ApoCell – Drug Profile 96
beclomethasone dipropionate – Drug Profile 97
begelomab – Drug Profile 99
bortezomib – Drug Profile 100
BPX-501 – Drug Profile 105
brentuximab vedotin – Drug Profile 107
budesonide – Drug Profile 112
Bz-423 – Drug Profile 115
cannabidiol – Drug Profile 116
Cell Therapy for Autoimmune Diseases and GVHD – Drug Profile 117
Cell Therapy for CNS, Respiratory, Immunology and Metabolic Disorders – Drug Profile 119
Cell Therapy for Graft Versus Host Disease – Drug Profile 120
Cell Therapy for Graft Versus Host Disease – Drug Profile 121
Cell Therapy for Graft Versus Host Disease – Drug Profile 122
Cell Therapy for Graft versus Host Disease – Drug Profile 123
Cell Therapy for Graft-Versus Host Disease – Drug Profile 124
Cell Therapy for GVHD – Drug Profile 125
cenicriviroc mesylate – Drug Profile 126
Cerecellgram for Graft Versus Host Disease – Drug Profile 128
clazakizumab – Drug Profile 129
Coversin – Drug Profile 131
cyclosporine IR + cyclosporine CR – Drug Profile 132
defibrotide – Drug Profile 133
Drugs for Acute and Chronic GVHD – Drug Profile 136
Drugs for Graft Versus Host Disease – Drug Profile 137
erismodegib – Drug Profile 138
F-652 – Drug Profile 141
Fc-Alpha-1 Antitrypsin – Drug Profile 142
FcAAT-2 – Drug Profile 143
FcAAT-3 – Drug Profile 144
Ha-7 – Drug Profile 145
ibrutinib – Drug Profile 146
ImmuneSafe – Drug Profile 152
ImmuStem – Drug Profile 153
IMO-8400 – Drug Profile 154
inolimomab – Drug Profile 156
IT-603 – Drug Profile 157
IT-901 – Drug Profile 158
KD-025 – Drug Profile 159
KY-1005 – Drug Profile 161
milatuzumab – Drug Profile 162
Monoclonal Antibody to Inhibit CD3 for Autoimmune Disorders, CNS Disorders, Infectious Diseases, Liver Diseases, Metabolic Disorders and Cardiovascular Diseases – Drug Profile 164
MSM-707 – Drug Profile 166
MultiStem – Drug Profile 167
natalizumab – Drug Profile 170
Oligonucleotide to Inhibit NFAT1 for GVHD – Drug Profile 172
panobinostat – Drug Profile 173
PLX-RAD – Drug Profile 179
Protein to Activate TLR5 for Infectious Disease and GVHD – Drug Profile 182
Recombinant HIV Gp120 Protein for GvHD And Autoimmune Disorders – Drug Profile 183
Recombinant Protein to Inhibit ILT3 for Graft Versus Host Disease – Drug Profile 184
remestemcel-L – Drug Profile 185
RGI-2001 – Drug Profile 188
RO-2959 – Drug Profile 190
Small Molecule for Graft Versus Host Disease, Hemophagocytic Lymphohistiocytosis and Autoimmune Disorders – Drug Profile 191
Small Molecule to Inhibit Protein Kinase C Theta for Autoimmune Disorder – Drug Profile 192
Small Molecules to Activate Telomerase for ALS, GVHD, Ageing and Leukemia – Drug Profile 193
Small Molecules to Inhibit SHIP1 for Oncology and Immunology – Drug Profile 194
SP-12008 – Drug Profile 195
T-Guard – Drug Profile 196
TZ-101 – Drug Profile 198
Graft Versus Host Disease (GVHD) – Recent Pipeline Updates 200
Graft Versus Host Disease (GVHD) – Dormant Projects 283
Graft Versus Host Disease (GVHD) – Discontinued Products 287
Graft Versus Host Disease (GVHD) – Product Development Milestones 288
Featured News & Press Releases 288
Appendix 296
Methodology 296
Coverage 296
Secondary Research 296
Primary Research 296
Expert Panel Validation 296
Contact Us 296
Disclaimer 297
【レポート販売概要】
■ タイトル：移植片対宿主病(Graft Versus Host Disease (GVHD))：治療薬開発パイプライン動向（2015年上半期版）■ 英文：Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2015
■ 発行日：2015年3月19日
■ 調査会社：Global Markets Direct
■ 商品コード：GMDHC6249IDB
■ 調査対象地域：グローバル
- レーダーシステム及び技術の世界市場2016-2020About Radar Systems and Technology Since World War II, the defense forces are using different radar systems and technologies to detect and track insights and information. Radars determine range, angle, and velocity of an object. They are also used to map and locate weather conditions for the army, air force, and naval operations. Receivers and transmitters are vital components of a radar system si …
- Xarelto（ACS/急性冠症候群）：医薬品市場予測及び分析（～2023）Xarelto (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Xarelto (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023”. The current ACS market - primarily comprised of antithrombotics, antihypertensives, and statins - is flush with well-established standard-of-care therapies, many of which are …
- 特権ID管理の世界市場予測（～2021年）MarketsandMarkets expects the privileged identity management market size to grow from USD 922.0 Million in 2016 to USD 3,792.5 Million by 2021, at a Compound Annual Growth Rate (CAGR) of 32.7%. The constant pressure of managing data breaches, along with the need to improve productivity and reduce costs has led enterprises of all sizes to adopt privileged identity management solutions for critical …
- 貴重品輸送警備サービスの世界市場About Secure Logistics Secure logistics refer to physical transportation of cash and other valuables from one location to another. It involves guarding and manning high-risk zones such as embassies, airports, and public venues. Cash services and providing security to important venues form the major part of secure logistics. Cash services include a gamut of services such as ATM services, armored ca …
- 駐車場管理ソリューションの世界市場2019-2023About this market Use of LPWAN technologies to drive market growth. loT is the foundation on which the connectivity platform for smart parking projects is built. LPWAN is one such technology that loT devices use to communicate with one another. LoRa, Sigfox, and NB-IoT are different types of LPWAN technologies that are being tested and deployed in smart parking projects. The choice of technology i …
- 飼料用リン酸の世界市場予測Feed phosphates are added into animal feed to improve the quality in terms of nutrient content, optimized animal performance, enhanced feed digestibility, preventative health maintenance, and to improve the quality of products derived from animals. Feed phosphate is prepared from a mixture of phosphoric acid and calcium carbonate/calcium sulphate. It is the best source of phosphorus essential for …
- 燃料電池技術の分析：Analyzing Fuel Cell TechnologyThe race for developing a long term solution to increasing usage of fossil fuels in the automotive sector and the rising effect of greenhouse gases has a new participant ? Fuel Cell Technology. The advent of Fuel Cells though yet to achieve mass commercial successes has presented new clean opportunities for meeting energy requirements. The rising fuel prices globally and the increasing environment …
- SandRidge Energy, Inc.：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013SandRidge Energy, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary SandRidge Energy, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential sour …
- 情報管理ソフトウェア市場：Kableの市場機会予測レポートProduct Synopsis Kable's Market Opportunity Forecast outlines the primary findings from our ongoing research into the dynamics in the Information Management market. Introduction and Landscape This product provides revenue opportunity forecasts in the Information Management market from 2014 to 2018, spanning four technology segments, 37 geographical markets, 6 regions, 14 verticals and two size ban …
- 封入体筋炎(Inclusion Body Myositis (IBM))：治療薬開発パイプライン動向（2015年上半期版）Inclusion Body Myositis (IBM) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Inclusion Body Myositis (IBM) - Pipeline Review, H1 2015’, provides an overview of the Inclusion Body Myositis (IBM)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Inclusion Body Myositis (IBM), complete with comparative analysis at various stages, t …
- ナノ粒子 – 金属および金属酸化物の世界市場分析：タイプ別（金、銀、酸化鉄、アルミナ、ガドリニウム、セリウム）、用途別（インビボイメージング、標的薬物送達、プロトン療法、インビトロアッセイ）、セグメント予測、2013-2025The global nanoparticles - metal & metal oxides market in healthcare is anticipated to reach USD 80.74 billion by 2025, according to a new report by Grand View Research, Inc. Several nanotechnologies based medicines have been put forward for approval by the FDA which is anticipated to propel growth. Success of nanomedicine has prompted the development of enhanced nanomaterials for clinical applica …
- アジアの石油・ガスパイプライン産業見通しOil and Gas Pipelines Industry Outlook in Asia and Oceania to 2020 - Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Pipelines Summary "Oil and Gas Pipelines Industry Outlook in Asia and Oceania to 2020 - Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Pipelines" is a comprehensive report on major, trunk oil and gas pipeline …
- 抜毛症（トリコチロマニア）：治療薬の治験動向（2014年下半期）Trichotillomania Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Trichotillomania Global Clinical Trials Review, H2, 2014" provides data on the Trichotillomania clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Trichotillomania. It includes an overview of the trial numbers and their recruitment statu …
- 電子パッケージングの世界市場：RFID、電子式商品監視（EAS）About Electronic Packaging Electronic packaging involves the use of engineering and other technologies to incorporate in-built security and protective features in the packaging of products. The use of electronics in packaging is gaining importance as it reduces wastage and enhances safety and security, product differentiation, convenience, brand enhancement, and quality assurance. Printed electron …
- バージ輸送のヨーロッパ市場2017-2021ABSTRACTAbout Barge Transportation Barge transportation refers to the mode of transporting dry and liquid bulk commodities in a barge vessel (a flat-bottomed boat) through rivers and canals. Some barges have to be pushed or towed, while others are self-propelled. Barge transportation is a sustainable mode of transportation and is environment-friendly, with respect to emission of CO₂ (carbon dioxid …
